326 related articles for article (PubMed ID: 28184875)
1. Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia.
Wimberley T; Gasse C; Meier SM; Agerbo E; MacCabe JH; Horsdal HT
Schizophr Bull; 2017 Sep; 43(5):1064-1069. PubMed ID: 28184875
[TBL] [Abstract][Full Text] [Related]
2. Schizophrenia polygenic risk scores, urbanicity and treatment-resistant schizophrenia.
Gasse C; Wimberley T; Wang Y; Mors O; Børglum A; Als TD; Werge T; Nordentoft M; Hougaard DM; Horsdal HT
Schizophr Res; 2019 Oct; 212():79-85. PubMed ID: 31447354
[TBL] [Abstract][Full Text] [Related]
3. Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
Pardiñas AF; Smart SE; Willcocks IR; Holmans PA; Dennison CA; Lynham AJ; Legge SE; Baune BT; Bigdeli TB; Cairns MJ; Corvin A; Fanous AH; Frank J; Kelly B; McQuillin A; Melle I; Mortensen PB; Mowry BJ; Pato CN; Periyasamy S; Rietschel M; Rujescu D; Simonsen C; St Clair D; Tooney P; Wu JQ; Andreassen OA; Kowalec K; Sullivan PF; Murray RM; Owen MJ; MacCabe JH; O'Donovan MC; Walters JTR; ; Ajnakina O; Alameda L; Barnes TRE; Berardi D; Bonora E; Camporesi S; Cleusix M; Conus P; Crespo-Facorro B; D'Andrea G; Demjaha A; Do KQ; Doody GA; Eap CB; Ferchiou A; Di Forti M; Guidi L; Homman L; Jenni R; Joyce EM; Kassoumeri L; Khadimallah I; Lastrina O; Muratori R; Noyan H; O'Neill FA; Pignon B; Restellini R; Richard JR; Schürhoff F; Španiel F; Szöke A; Tarricone I; Tortelli A; Üçok A; Vázquez-Bourgon J
JAMA Psychiatry; 2022 Mar; 79(3):260-269. PubMed ID: 35019943
[TBL] [Abstract][Full Text] [Related]
4. Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish Population.
Musliner KL; Mortensen PB; McGrath JJ; Suppli NP; Hougaard DM; Bybjerg-Grauholm J; Bækvad-Hansen M; Andreassen O; Pedersen CB; Pedersen MG; Mors O; Nordentoft M; Børglum AD; Werge T; Agerbo E;
JAMA Psychiatry; 2019 May; 76(5):516-525. PubMed ID: 30698613
[TBL] [Abstract][Full Text] [Related]
5. Polygenic overlap with body-mass index improves prediction of treatment-resistant schizophrenia.
O'Connell KS; Koch E; Lenk HÇ; Akkouh IA; Hindley G; Jaholkowski P; Smith RL; Holen B; Shadrin AA; Frei O; Smeland OB; Steen NE; Dale AM; Molden E; Djurovic S; Andreassen OA
Psychiatry Res; 2023 Jul; 325():115217. PubMed ID: 37146461
[TBL] [Abstract][Full Text] [Related]
6. Systems-Level Analysis of Genetic Variants Reveals Functional and Spatiotemporal Context in Treatment-resistant Schizophrenia.
Talarico F; Costa GO; Ota VK; Santoro ML; Noto C; Gadelha A; Bressan R; Azevedo H; Belangero SI
Mol Neurobiol; 2022 May; 59(5):3170-3182. PubMed ID: 35278208
[TBL] [Abstract][Full Text] [Related]
7. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia.
Lin BD; Pinzón-Espinosa J; Blouzard E; van der Horst MZ; Okhuijsen-Pfeifer C; van Eijk KR; Guloksuz S; Peyrot WJ; Luykx JJ;
JAMA Psychiatry; 2023 Feb; 80(2):181-185. PubMed ID: 36542388
[TBL] [Abstract][Full Text] [Related]
8. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P
Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
[TBL] [Abstract][Full Text] [Related]
10. Polygenic risk score increases schizophrenia liability through cognition-relevant pathways.
Toulopoulou T; Zhang X; Cherny S; Dickinson D; Berman KF; Straub RE; Sham P; Weinberger DR
Brain; 2019 Feb; 142(2):471-485. PubMed ID: 30535067
[TBL] [Abstract][Full Text] [Related]
11. Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatment.
Tomasik J; Lago SG; Vázquez-Bourgon J; Papiol S; Suárez-Pinilla P; Crespo-Facorro B; Bahn S
JAMA Psychiatry; 2019 Aug; 76(8):864-867. PubMed ID: 30942838
[TBL] [Abstract][Full Text] [Related]
12. Polygenic Risk Score, Parental Socioeconomic Status, Family History of Psychiatric Disorders, and the Risk for Schizophrenia: A Danish Population-Based Study and Meta-analysis.
Agerbo E; Sullivan PF; Vilhjálmsson BJ; Pedersen CB; Mors O; Børglum AD; Hougaard DM; Hollegaard MV; Meier S; Mattheisen M; Ripke S; Wray NR; Mortensen PB
JAMA Psychiatry; 2015 Jul; 72(7):635-41. PubMed ID: 25830477
[TBL] [Abstract][Full Text] [Related]
13. Deconstructing the genetic architecture of treatment-resistant schizophrenia in East Asian ancestry.
Lim K; Yee JY; See YM; Ng BT; Zheng S; Tang C; Lencz T; Lee J; Lam M
Asian J Psychiatr; 2023 Dec; 90():103826. PubMed ID: 37944474
[TBL] [Abstract][Full Text] [Related]
14. Inverse association between urbanicity and treatment resistance in schizophrenia.
Wimberley T; Pedersen CB; MacCabe JH; Støvring H; Astrup A; Sørensen HJ; Horsdal HT; Mortensen PB; Gasse C
Schizophr Res; 2016 Jul; 174(1-3):150-155. PubMed ID: 27066856
[TBL] [Abstract][Full Text] [Related]
15. Association of Childhood Exposure to Nitrogen Dioxide and Polygenic Risk Score for Schizophrenia With the Risk of Developing Schizophrenia.
Horsdal HT; Agerbo E; McGrath JJ; Vilhjálmsson BJ; Antonsen S; Closter AM; Timmermann A; Grove J; Mok PLH; Webb RT; Sabel CE; Hertel O; Sigsgaard T; Erikstrup C; Hougaard DM; Werge T; Nordentoft M; Børglum AD; Mors O; Mortensen PB; Brandt J; Geels C; Pedersen CB
JAMA Netw Open; 2019 Nov; 2(11):e1914401. PubMed ID: 31675084
[TBL] [Abstract][Full Text] [Related]
16. Validation of an algorithm-based definition of treatment resistance in patients with schizophrenia.
Ajnakina O; Horsdal HT; Lally J; MacCabe JH; Murray RM; Gasse C; Wimberley T
Schizophr Res; 2018 Jul; 197():294-297. PubMed ID: 29472163
[TBL] [Abstract][Full Text] [Related]
17. Polygenic risk score prediction of antipsychotic dosage in schizophrenia.
Hettige NC; Cole CB; Khalid S; De Luca V
Schizophr Res; 2016 Feb; 170(2-3):265-70. PubMed ID: 26778674
[TBL] [Abstract][Full Text] [Related]
18. Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study.
Lin AS; Chan HY; Peng YC; Chen WJ
BMC Psychiatry; 2019 Jul; 19(1):220. PubMed ID: 31299940
[TBL] [Abstract][Full Text] [Related]
19. Indicated association between polygenic risk score and treatment-resistance in a naturalistic sample of patients with schizophrenia spectrum disorders.
Werner MCF; Wirgenes KV; Haram M; Bettella F; Lunding SH; Rødevand L; Hjell G; Agartz I; Djurovic S; Melle I; Andreassen OA; Steen NE
Schizophr Res; 2020 Apr; 218():55-62. PubMed ID: 32171635
[TBL] [Abstract][Full Text] [Related]
20. Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study.
Wimberley T; Støvring H; Sørensen HJ; Horsdal HT; MacCabe JH; Gasse C
Lancet Psychiatry; 2016 Apr; 3(4):358-66. PubMed ID: 26922475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
